Stay updated on MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Sign up to get notified when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.

Latest updates to the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page
- Check4 days agoChange DetectedLocalization and version update: the location string changes from 'Mexico, Mexico, 06720' to 'México, Mexico, 06720' and the revision becomes v3.0.2, with the 'Back to Top' element removed.SummaryDifference0.2%
- Check11 days agoChange DetectedThe page has been updated to include a new reference on parental knowledge and attitudes towards infant immunization related to RSV, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference1%
- Check18 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as detailed drug information for Nirsevimab, while also correcting the total number of study locations from 199 to 198. Several previous locations and terms have been removed.SummaryDifference23%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI8897 Efficacy in Infant RSV Prevention Clinical Trial page.